Transitioning To IV Remodulin From Ventavis in Patients With PAH: Safety, Efficacy and Treatment Satisfaction

NCT00458042 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

10

Enrollment

INDUSTRY

Sponsor class

Stopped Low Enrollment

Conditions

Hypertension, Pulmonary

Interventions

DRUG: treprostinil sodium

Sponsor

United Therapeutics